HR of death for all patients with cancer according to their care experience with cancer clinical nurse specialists (CNS)
| Experience type | Adjustments | Model 1 | Model 2 | Model 3 | Sensitivity analysis* | ||||
| Age and sex | Age, sex and stage | All covariables | All covariables | ||||||
| Colorectal cancer | Experience level | HR | 95% CI | HR | 95% CI | HR | 95% CI | HR | 95% CI |
| CNS name | Not given | 1.78 | 1.68 to 1.88 | 1.60 | 1.51 to 1.69 | 1.40 | 1.32 to 1.84 | 1.37 | 1.05 to 1.62 |
| Contact CNS | Excellent | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Non-excellent | 1.22 | 1.16 to 1.28 | 1.12 | 1.07 to 1.19 | 1.13 | 1.07 to 1.18 | 1.07 | 1.00 to 1.16 | |
| CNS listening | Excellent | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Non-excellent | 1.31 | 1.21 to 1.41 | 1.24 | 1.15 to 1.34 | 1.21 | 1.14 to 1.31 | 1.19 | 1.06 to 1.33 | |
| Understand CNS | Excellent | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Non-excellent | 1.30 | 1.21 to 1.41 | 1.24 | 1.15 to 1.33 | 1.22 | 1.12 to 1.30 | 1.18 | 1.05 to 1.32 | |
| Lung cancer | |||||||||
| CNS name | Not given | 0.79 | 0.74 to 0.86 | 0.91 | 0.84 to 0.98 | 0.92 | 0.84 to 0.99 | 0.87 | 0.79 to 0.95 |
| Contact CNS | Excellent | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Non-excellent | 1.09 | 1.04 to 1.14 | 1.04 | 0.99 to 1.09 | 1.05 | 1.00 to 1.10 | 1.00 | 0.95 to 1.07 | |
| CNS listening | Excellent | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Non-excellent | 0.98 | 0.91 to 1.06 | 1.03 | 0.96 to 1.11 | 1.04 | 0.97 to 1.12 | 1.01 | 0.92 to 1.10 | |
| Understand CNS | Excellent | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Non-excellent | 1.04 | 0.98 to 1.12 | 1.04 | 0.98 to 1.12 | 1.04 | 0.97 to 1.12 | 0.98 | 0.89 to 1.06 | |
| Breast cancer | |||||||||
| CNS name | Not given | 1.94 | 1.82 to 2.08 | 1.72 | 1.61 to 1.84 | 1.34 | 1.25 to 1.44 | 1.05 | 0.85 to 1.09 |
| Contact CNS | Excellent | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Non-excellent | 1.06 | 1.01 to 1.11 | 1.02 | 0.97 to 1.07 | 1.03 | 0.98 to 1.08 | 0.96 | 0.85 to 1.09 | |
| CNS listening | Excellent | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Non-excellent | 1.19 | 1.11 to 1.28 | 1.12 | 1.10 to 1.27 | 1.15 | 1.07 to 1.23 | 1.15 | 0.97 to 1.37 | |
| Understand CNS | Excellent | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Non-excellent | 1.36 | 1.26 to 1.46 | 1.25 | 1.16 to 1.34 | 1.23 | 1.14 to 1.31 | 1.06 | 0.87 to 1.28 | |
| Prostate cancer | |||||||||
| CNS name | Not given | 1.58 | 1.48 to 1.69 | 1.42 | 1.33 to 1.51 | 1.09 | 0.99 to 1.13 | 1.09 | 0.88 to 1.24 |
| Contact CNS | Excellent | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Non-excellent | 1.01 | 0.94 to 1.07 | 1.02 | 0.95 to 1.09 | 1.05 | 0.95 to 1.07 | 0.99 | 0.87 to 1.28 | |
| CNS listening | Excellent | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Non-excellent | 1.21 | 1.09 to 1.32 | 1.14 | 0.04 to 1.25 | 1.11 | 1.00 to 1.20 | 1.03 | 0.86 to 1.25 | |
| Understand CNS | Excellent | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Non-excellent | 1.35 | 1.23 to 1.49 | 1.30 | 1.13 to 1.42 | 1.26 | 1.15 to 1.39 | 1.23 | 1.01 to 1.49 | |
Model 1: excellent experience as a reference and adjusting sex (for patients with lung and colorectal cancer) and age; model 2: excellent experience as a reference and adjusting sex, age and stage; model 3: excellent experience as a reference and adjusting sex, age, ethnicity, areas, deprivation, route to diagnosis (unknown as a category), stage at diagnosis (unknown as a category) and time since diagnosis in days.
*Sensitivity analysis: same as model 3 but eliminating patients with the worst outcomes based on the least 25% quartile of survival time (in days).